Pancreatic Cancer Research

ResearcherJewish General HospitalActive in the last 2 years

Gerald Batist

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-5430-3750; OpenAlex author ID A5029097581. Sources: ClinicalTrials.gov.

Their work

Papers
3
Trials
2 (principal investigator on 1)
Grants
0
Labs led
0
Collaborators
10
Papers, trials and grants by year

2006: 1 trial · 2007: none · 2008: none · 2009: none · 2010: none · 2011: none · 2012: none · 2013: none · 2014: none · 2015: none · 2016: none · 2017: 1 paper · 2018: none · 2019: none · 2020: 1 trial · 2021: none · 2022: none · 2023: none · 2024: 1 paper · 2025: none · 2026: 1 paper

Papers 3

  1. A phase 2 study of orally administered live biotherapeutic salmonella-IL2 with FOLFIRINOX for stage IV pancreatic cancer. Co-author DOI 10.1007/s00262-026-04307-0↗
  2. Feasibility and safety of endoscopic ultrasound-guided diffusing alpha emitter radiation therapy for advanced pancreatic cancer: Preliminary data. Co-author DOI 10.1055/a-2379-1591↗
  3. Evaluation of gemcitabine efficacy after the FOLFIRINOX regimen in patients with advanced pancreatic adenocarcinoma. Co-author DOI 10.1097/md.0000000000006544↗

Trials 2

  1. Saltikva for Metastatic Pancreatic Cancer Principal investigator NCT04589234↗
  2. A Phase I Study of ECO-4601 in Patients With Advanced Cancer Study chair NCT00338026↗

Closest collaborators

The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Petr Kavan · 3 shared papers, 1 shared trial, 2006–2026 · strength 0.61
  2. Daniel A. Saltzman · 1 shared paper, 2026 · strength 0.33
  3. Anand V. Sahai · 1 shared paper, 2024 · strength 0.18
  4. David Donath · 1 shared paper, 2024 · strength 0.18
  5. Corey Miller · 1 shared paper, 2024 · strength 0.18
  6. Olivıer Turrini · 1 shared paper, 2017 · strength 0.07
  7. Brice Chanez · 1 shared paper, 2017 · strength 0.07
  8. Jean‐Luc Raoul · 1 shared paper, 2017 · strength 0.07
  9. Marine Gilabert · 1 shared paper, 2017 · strength 0.07
  10. Benoît Samson · 1 shared trial, 2006 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.